Peptidoglycan from Staphylococcus aureus induces IL-4 production from murine spleen cells via an IL-18-dependent mechanism

International Archives of Allergy and Immunology

Volumn 146, Issue 3, 2008, Pages 262-266

  Matsui, Katsuhiko ^a   Wirotesangthong, Mali ^b   Nishikawa, Akemi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Atopic dermatitis; IL 18; IL 4; Peptidoglycan; Staphylococcus aureus

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PEPTIDOGLYCAN; PHOSPHATE BUFFERED SALINE;

ABDOMEN; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; TH2 CELL;

ADMINISTRATION, CUTANEOUS; ANIMALS; DERMATITIS, ATOPIC; FEMALE; INTERLEUKIN-18; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PEPTIDOGLYCAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; STAPHYLOCOCCUS AUREUS;

EID: 45149126935     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116363     Document Type: Article

References (14)

1. Leung DYM: Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-319.
2. Gloor M, Peters G, Stoika D: On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in healthy controls. Dermatologica 1982;164:258-265.
3. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H: Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis. Microbiol Immunol 2000;44:945-947.
4. Lambert PA, Hancock IC, Baddiley J: Occurrence and function of membrane teichoic acids. Biochim Biophys Acta 1977;472:1-12.
5. Fischer W: Bacterial phosphoglycolipids and lipoteichoic acids; in Hannah DJ (ed): Handbook of Lipid Research. New York, Plenum, 1989, pp 123-234.
6. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H: Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6. FEMS Immunol Med Microbiol 1993;7:281-287.
7. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR: The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995;92:10359-10363.
8. Matsui K, Nishikawa A: Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice. Clin Exp Allergy 2005;35:382-387.
9. Matsui K, Wirotesangthong M, Nishikawa A: Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin. Clin Exp Allergy 2007;37:615-622.
10. + T cells, IL-4 and STAT6. Nat Immunol 2000;1:132-137.
11. + T cells. Eur J Immunol 2000;30:1998-2006.
12. Tanaka T, Tsutsui H, Yoshimoto T, Kotani M, Masumoto M, Fujita A, Wang W, Higa S, Kishimoto T, Nakanishi K, Suemura M: Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int Arch Allergy Immunol 2001;125:236-240.
13. Re F, Strominger JL: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001;276:37692-37699.
14. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-526.